Review





Similar Products

atcc product code  (ATCC)
99
ATCC atcc product code
Atcc Product Code, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atcc product code/product/ATCC
Average 99 stars, based on 1 article reviews
atcc product code - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
primary cd14 human peripheral blood monocytes hpbms  (PromoCell)
90
PromoCell primary cd14 human peripheral blood monocytes hpbms
A Schematic of DEX treatment during macrophage differentiation (day 0–6). B mRNA expression of the M1 markers CCR7 , CD80 , PTGS2 , and IL1B ( n = 3 [ CCR7 ], 4), and C ) M2 markers CD163 and MRC1 ( n = 3). D Schematic of DEX treatment during macrophage M1 polarization (day 6–8). E mRNA expression of M1 markers ( n = 3 [ PTGS2, IL1B ], 5 [ CCR7, CD80 ]), and F ) M2 markers ( n = 3, 4 [M2 0, M1 0]). H Schematic of DEX treatment of M1 polarized macrophages (days 8–10). I mRNA expression of M1 markers ( n = 3) and J M2 markers ( n = 3). M2 macrophages were not DEX-treated, and comparisons were to M1 polarized macrophages at 0 nM DEX in ( A )–( J ). K mRNA expression of the M2 markers CD163 and MRC1 , and NR3C1 (GR) in primary human peripheral blood monocyte-derived macrophages (hMDMs) after 2 days of vehicle or 100 nM DEX treatment. All mRNA expression was relative to untreated THP-1 cells and normalized to the housekeeping gene HPRT1 in B , C , E , F , I , J , and relative to untreated <t>CD14</t> + hPBM cells and normalized to HPRT1 in K. Bars represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001. Statistical significance was determined using one-way ANOVA followed by Dunnett’s multiple comparisons correction in B , C , E , F , I , J , and using Student’s unpaired t -test in ( K ).
Primary Cd14 Human Peripheral Blood Monocytes Hpbms, supplied by PromoCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary cd14 human peripheral blood monocytes hpbms/product/PromoCell
Average 90 stars, based on 1 article reviews
primary cd14 human peripheral blood monocytes hpbms - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
peripheral blood cd14 monocytes pbmc  (ATCC)
99
ATCC peripheral blood cd14 monocytes pbmc
A Schematic of DEX treatment during macrophage differentiation (day 0–6). B mRNA expression of the M1 markers CCR7 , CD80 , PTGS2 , and IL1B ( n = 3 [ CCR7 ], 4), and C ) M2 markers CD163 and MRC1 ( n = 3). D Schematic of DEX treatment during macrophage M1 polarization (day 6–8). E mRNA expression of M1 markers ( n = 3 [ PTGS2, IL1B ], 5 [ CCR7, CD80 ]), and F ) M2 markers ( n = 3, 4 [M2 0, M1 0]). H Schematic of DEX treatment of M1 polarized macrophages (days 8–10). I mRNA expression of M1 markers ( n = 3) and J M2 markers ( n = 3). M2 macrophages were not DEX-treated, and comparisons were to M1 polarized macrophages at 0 nM DEX in ( A )–( J ). K mRNA expression of the M2 markers CD163 and MRC1 , and NR3C1 (GR) in primary human peripheral blood monocyte-derived macrophages (hMDMs) after 2 days of vehicle or 100 nM DEX treatment. All mRNA expression was relative to untreated THP-1 cells and normalized to the housekeeping gene HPRT1 in B , C , E , F , I , J , and relative to untreated <t>CD14</t> + hPBM cells and normalized to HPRT1 in K. Bars represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001. Statistical significance was determined using one-way ANOVA followed by Dunnett’s multiple comparisons correction in B , C , E , F , I , J , and using Student’s unpaired t -test in ( K ).
Peripheral Blood Cd14 Monocytes Pbmc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peripheral blood cd14 monocytes pbmc/product/ATCC
Average 99 stars, based on 1 article reviews
peripheral blood cd14 monocytes pbmc - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
primary peripheral blood cd14 monocytes pbmc human atcc product code  (ATCC)
99
ATCC primary peripheral blood cd14 monocytes pbmc human atcc product code
A Schematic of DEX treatment during macrophage differentiation (day 0–6). B mRNA expression of the M1 markers CCR7 , CD80 , PTGS2 , and IL1B ( n = 3 [ CCR7 ], 4), and C ) M2 markers CD163 and MRC1 ( n = 3). D Schematic of DEX treatment during macrophage M1 polarization (day 6–8). E mRNA expression of M1 markers ( n = 3 [ PTGS2, IL1B ], 5 [ CCR7, CD80 ]), and F ) M2 markers ( n = 3, 4 [M2 0, M1 0]). H Schematic of DEX treatment of M1 polarized macrophages (days 8–10). I mRNA expression of M1 markers ( n = 3) and J M2 markers ( n = 3). M2 macrophages were not DEX-treated, and comparisons were to M1 polarized macrophages at 0 nM DEX in ( A )–( J ). K mRNA expression of the M2 markers CD163 and MRC1 , and NR3C1 (GR) in primary human peripheral blood monocyte-derived macrophages (hMDMs) after 2 days of vehicle or 100 nM DEX treatment. All mRNA expression was relative to untreated THP-1 cells and normalized to the housekeeping gene HPRT1 in B , C , E , F , I , J , and relative to untreated <t>CD14</t> + hPBM cells and normalized to HPRT1 in K. Bars represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001. Statistical significance was determined using one-way ANOVA followed by Dunnett’s multiple comparisons correction in B , C , E , F , I , J , and using Student’s unpaired t -test in ( K ).
Primary Peripheral Blood Cd14 Monocytes Pbmc Human Atcc Product Code, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary peripheral blood cd14 monocytes pbmc human atcc product code/product/ATCC
Average 99 stars, based on 1 article reviews
primary peripheral blood cd14 monocytes pbmc human atcc product code - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
human cd14 + peripheral blood-derived monocytes  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc human cd14 + peripheral blood-derived monocytes
A) Higher levels of resistin significantly positively correlated to delta values in KOOS Sports/Rec scores at 24 months. Higher levels of TIMP1 and CCL2 significantly correlated inversely to the percentage change and/or delta in KOOS Sports/Rec scores at 24 months relative to baseline. B) Higher levels of HGF and VEGFA in synovial fluid significantly correlated inversely to delta values and/or percentage change in KOOS Pain scores at 12 months relative to baseline. C) Higher levels of sCD14 and CCL2 significantly correlate inversely to the percentage change and/or delta in KOOS Symptom and Sports/Rec scores at 3 months relative to baseline. Delta and percent change in KOOS values were made relative to baseline and calculated such that positive values represent improvement. N=8-9 patients. Spearman’s correlation. Sports/Rec: function in sport and recreation; MO: month; KOOS: knee injury and osteoarthritis outcome score; TIMP1: tissue inhibitor of metalloproteinases 1; CCL2: chemokine C-C motif ligand 2; HGF: hepatocyte growth factor; sCD14: soluble <t>CD14;</t> VEGFA: vascular endothelial growth factor A.
Human Cd14 + Peripheral Blood Derived Monocytes, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cd14 + peripheral blood-derived monocytes/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
human cd14 + peripheral blood-derived monocytes - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human peripheral blood cd14 + monocytes cryopreserved zenbio ser-cd14-f  (ZenBio)
90
ZenBio human peripheral blood cd14 + monocytes cryopreserved zenbio ser-cd14-f
A) Higher levels of resistin significantly positively correlated to delta values in KOOS Sports/Rec scores at 24 months. Higher levels of TIMP1 and CCL2 significantly correlated inversely to the percentage change and/or delta in KOOS Sports/Rec scores at 24 months relative to baseline. B) Higher levels of HGF and VEGFA in synovial fluid significantly correlated inversely to delta values and/or percentage change in KOOS Pain scores at 12 months relative to baseline. C) Higher levels of sCD14 and CCL2 significantly correlate inversely to the percentage change and/or delta in KOOS Symptom and Sports/Rec scores at 3 months relative to baseline. Delta and percent change in KOOS values were made relative to baseline and calculated such that positive values represent improvement. N=8-9 patients. Spearman’s correlation. Sports/Rec: function in sport and recreation; MO: month; KOOS: knee injury and osteoarthritis outcome score; TIMP1: tissue inhibitor of metalloproteinases 1; CCL2: chemokine C-C motif ligand 2; HGF: hepatocyte growth factor; sCD14: soluble <t>CD14;</t> VEGFA: vascular endothelial growth factor A.
Human Peripheral Blood Cd14 + Monocytes Cryopreserved Zenbio Ser Cd14 F, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human peripheral blood cd14 + monocytes cryopreserved zenbio ser-cd14-f/product/ZenBio
Average 90 stars, based on 1 article reviews
human peripheral blood cd14 + monocytes cryopreserved zenbio ser-cd14-f - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human  (ATCC)
99
ATCC human
A) Higher levels of resistin significantly positively correlated to delta values in KOOS Sports/Rec scores at 24 months. Higher levels of TIMP1 and CCL2 significantly correlated inversely to the percentage change and/or delta in KOOS Sports/Rec scores at 24 months relative to baseline. B) Higher levels of HGF and VEGFA in synovial fluid significantly correlated inversely to delta values and/or percentage change in KOOS Pain scores at 12 months relative to baseline. C) Higher levels of sCD14 and CCL2 significantly correlate inversely to the percentage change and/or delta in KOOS Symptom and Sports/Rec scores at 3 months relative to baseline. Delta and percent change in KOOS values were made relative to baseline and calculated such that positive values represent improvement. N=8-9 patients. Spearman’s correlation. Sports/Rec: function in sport and recreation; MO: month; KOOS: knee injury and osteoarthritis outcome score; TIMP1: tissue inhibitor of metalloproteinases 1; CCL2: chemokine C-C motif ligand 2; HGF: hepatocyte growth factor; sCD14: soluble <t>CD14;</t> VEGFA: vascular endothelial growth factor A.
Human, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human/product/ATCC
Average 99 stars, based on 1 article reviews
human - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
primary peripheral bloodcd14 monocytes  (ATCC)
99
ATCC primary peripheral bloodcd14 monocytes
A) Higher levels of resistin significantly positively correlated to delta values in KOOS Sports/Rec scores at 24 months. Higher levels of TIMP1 and CCL2 significantly correlated inversely to the percentage change and/or delta in KOOS Sports/Rec scores at 24 months relative to baseline. B) Higher levels of HGF and VEGFA in synovial fluid significantly correlated inversely to delta values and/or percentage change in KOOS Pain scores at 12 months relative to baseline. C) Higher levels of sCD14 and CCL2 significantly correlate inversely to the percentage change and/or delta in KOOS Symptom and Sports/Rec scores at 3 months relative to baseline. Delta and percent change in KOOS values were made relative to baseline and calculated such that positive values represent improvement. N=8-9 patients. Spearman’s correlation. Sports/Rec: function in sport and recreation; MO: month; KOOS: knee injury and osteoarthritis outcome score; TIMP1: tissue inhibitor of metalloproteinases 1; CCL2: chemokine C-C motif ligand 2; HGF: hepatocyte growth factor; sCD14: soluble <t>CD14;</t> VEGFA: vascular endothelial growth factor A.
Primary Peripheral Bloodcd14 Monocytes, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary peripheral bloodcd14 monocytes/product/ATCC
Average 99 stars, based on 1 article reviews
primary peripheral bloodcd14 monocytes - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


A Schematic of DEX treatment during macrophage differentiation (day 0–6). B mRNA expression of the M1 markers CCR7 , CD80 , PTGS2 , and IL1B ( n = 3 [ CCR7 ], 4), and C ) M2 markers CD163 and MRC1 ( n = 3). D Schematic of DEX treatment during macrophage M1 polarization (day 6–8). E mRNA expression of M1 markers ( n = 3 [ PTGS2, IL1B ], 5 [ CCR7, CD80 ]), and F ) M2 markers ( n = 3, 4 [M2 0, M1 0]). H Schematic of DEX treatment of M1 polarized macrophages (days 8–10). I mRNA expression of M1 markers ( n = 3) and J M2 markers ( n = 3). M2 macrophages were not DEX-treated, and comparisons were to M1 polarized macrophages at 0 nM DEX in ( A )–( J ). K mRNA expression of the M2 markers CD163 and MRC1 , and NR3C1 (GR) in primary human peripheral blood monocyte-derived macrophages (hMDMs) after 2 days of vehicle or 100 nM DEX treatment. All mRNA expression was relative to untreated THP-1 cells and normalized to the housekeeping gene HPRT1 in B , C , E , F , I , J , and relative to untreated CD14 + hPBM cells and normalized to HPRT1 in K. Bars represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001. Statistical significance was determined using one-way ANOVA followed by Dunnett’s multiple comparisons correction in B , C , E , F , I , J , and using Student’s unpaired t -test in ( K ).

Journal: Cell Death & Disease

Article Title: Dexamethasone drives macrophage repolarization linked to increased triple-negative breast cancer aggressiveness

doi: 10.1038/s41419-025-08363-9

Figure Lengend Snippet: A Schematic of DEX treatment during macrophage differentiation (day 0–6). B mRNA expression of the M1 markers CCR7 , CD80 , PTGS2 , and IL1B ( n = 3 [ CCR7 ], 4), and C ) M2 markers CD163 and MRC1 ( n = 3). D Schematic of DEX treatment during macrophage M1 polarization (day 6–8). E mRNA expression of M1 markers ( n = 3 [ PTGS2, IL1B ], 5 [ CCR7, CD80 ]), and F ) M2 markers ( n = 3, 4 [M2 0, M1 0]). H Schematic of DEX treatment of M1 polarized macrophages (days 8–10). I mRNA expression of M1 markers ( n = 3) and J M2 markers ( n = 3). M2 macrophages were not DEX-treated, and comparisons were to M1 polarized macrophages at 0 nM DEX in ( A )–( J ). K mRNA expression of the M2 markers CD163 and MRC1 , and NR3C1 (GR) in primary human peripheral blood monocyte-derived macrophages (hMDMs) after 2 days of vehicle or 100 nM DEX treatment. All mRNA expression was relative to untreated THP-1 cells and normalized to the housekeeping gene HPRT1 in B , C , E , F , I , J , and relative to untreated CD14 + hPBM cells and normalized to HPRT1 in K. Bars represent mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001. Statistical significance was determined using one-way ANOVA followed by Dunnett’s multiple comparisons correction in B , C , E , F , I , J , and using Student’s unpaired t -test in ( K ).

Article Snippet: In addition, primary CD14 + human peripheral blood monocytes (hPBMs) were purchased from PromoCell (#C-14110) as a single-donor cell pellet stored in RNA later ® .

Techniques: Expressing, Derivative Assay

A) Higher levels of resistin significantly positively correlated to delta values in KOOS Sports/Rec scores at 24 months. Higher levels of TIMP1 and CCL2 significantly correlated inversely to the percentage change and/or delta in KOOS Sports/Rec scores at 24 months relative to baseline. B) Higher levels of HGF and VEGFA in synovial fluid significantly correlated inversely to delta values and/or percentage change in KOOS Pain scores at 12 months relative to baseline. C) Higher levels of sCD14 and CCL2 significantly correlate inversely to the percentage change and/or delta in KOOS Symptom and Sports/Rec scores at 3 months relative to baseline. Delta and percent change in KOOS values were made relative to baseline and calculated such that positive values represent improvement. N=8-9 patients. Spearman’s correlation. Sports/Rec: function in sport and recreation; MO: month; KOOS: knee injury and osteoarthritis outcome score; TIMP1: tissue inhibitor of metalloproteinases 1; CCL2: chemokine C-C motif ligand 2; HGF: hepatocyte growth factor; sCD14: soluble CD14; VEGFA: vascular endothelial growth factor A.

Journal: bioRxiv

Article Title: Responders vs. non-responders to mesenchymal stromal cells in knee osteoarthritis patients: mechanistic correlates of donor cell attributes and patient features

doi: 10.1101/2025.07.17.665028

Figure Lengend Snippet: A) Higher levels of resistin significantly positively correlated to delta values in KOOS Sports/Rec scores at 24 months. Higher levels of TIMP1 and CCL2 significantly correlated inversely to the percentage change and/or delta in KOOS Sports/Rec scores at 24 months relative to baseline. B) Higher levels of HGF and VEGFA in synovial fluid significantly correlated inversely to delta values and/or percentage change in KOOS Pain scores at 12 months relative to baseline. C) Higher levels of sCD14 and CCL2 significantly correlate inversely to the percentage change and/or delta in KOOS Symptom and Sports/Rec scores at 3 months relative to baseline. Delta and percent change in KOOS values were made relative to baseline and calculated such that positive values represent improvement. N=8-9 patients. Spearman’s correlation. Sports/Rec: function in sport and recreation; MO: month; KOOS: knee injury and osteoarthritis outcome score; TIMP1: tissue inhibitor of metalloproteinases 1; CCL2: chemokine C-C motif ligand 2; HGF: hepatocyte growth factor; sCD14: soluble CD14; VEGFA: vascular endothelial growth factor A.

Article Snippet: Indirect co-culture of unmatched human CD14 + peripheral blood-derived monocytes (STEMCELL Technologies, Vancouver, Canada) with biobanked MSC(M) was performed as previously described [ ].

Techniques: